Federal Agency · National Institutes of Health
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Last updated: July 27, 2026
Posted December 30, 2024
Funding
Up to $150K
Closes
August 11, 2027
NAICS
541714
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Program Details
National Institutes of Health is a federal agency that offers the Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) grant program to support rd grants. This funding opportunity is available nationally and is administered by National Institutes of Health through Grants.gov. Organizations seeking funding for rd grants should review the details below and confirm their eligibility before preparing an application.
Eligibility
Eligible applicants include tribal governments and Native American organizations, government agencies and municipalities, for-profit businesses, and eligible organizations. Organizations that meet the eligibility criteria are encouraged to apply and to review the full program guidelines before submission. Because eligibility rules and funding priorities can change between cycles, applicants should always confirm the current requirements with National Institutes of Health or on Grants.gov before investing time in an application.
Funding and Timeline
Funding available: Up to $150K. The application deadline is August 11, 2027 (379 days remaining). Applicants should allow sufficient time to gather required documentation, including organizational information, project descriptions, budgets, and supporting materials as specified in the program guidelines. Submitting a complete application well ahead of the deadline reduces the risk of disqualification on technical or administrative grounds.
Program Focus
This grant supports rd grants. This grant is associated with NAICS industry classifications: 541714, 621111, 621112, 622, 541715. Organizations operating in these sectors are encouraged to review eligibility. Funded projects are expected to demonstrate measurable outcomes aligned with the program's stated objectives. Grant recipients may be required to submit progress reports and final evaluations as a condition of the award, and to retain records for audit and compliance purposes.
How to Apply
Eligible organizations can apply through Grants.gov. Create a free organization profile on GrantRegister to see whether this grant matches your organization's NAICS code, entity type, location, and focus area, and to receive a weekly digest of every open grant you qualify for.
GrantRegister maintains a complete, authoritative registry of US federal, state, and foundation grant opportunities — matched automatically to your organization profile and delivered every Monday.
Eligibility
- Funded by NIH
- Programs related to basic research
Award details
Award range: Up to $150K. Applications close on August 11, 2027 (379 days remaining).
Categories
Rd Grants
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Jul 27, 2026
Similar grants
- ROSES25: B.5 Research and Development of Initiatives for Advanced New TechnologiesNASA Headquarters · closes April 27, 2026
- FY25 Center of Excellence-University of Illinois Urbana-Champaign (Supplemental)DOT - Federal Railroad Administration · closes May 8, 2026
- Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and ConfirmationGolden Field Office · closes May 14, 2026
- Fiscal Year 2026 Phase II Continuation Consolidated Innovative Nuclear ResearchIdaho Field Office · closes May 20, 2026
- FY2026 Research Opportunities in Accelerator Stewardship and Accelerator DevelopmentOffice of Science · closes May 21, 2026
- Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)National Institutes of Health · closes May 24, 2026
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)National Institutes of Health · closes May 24, 2026
- Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)National Institutes of Health · closes May 24, 2026
